The PLAC Test

is the only blood test

cleared by the FDA

to aid in assessing risk for both

coronary heart disease (CHD)

and ischemic stroke associated

with atherosclerosis.

For Healthcare Professionals

The PLAC® Test for Lp-PLA2 is the only blood test that helps identify hidden risk for heart attack and stroke. Early detection and more aggressive treatment can help prevent these events. >

For Lab Professionals

Learn more about how you can run the PLAC Test in your lab. We answer technical questions you may have about the PLAC Test and how it can be used to help assess risk for heart attack and stroke.>

For Patients

Learn more about your risk for stroke and cardiovascular disease prevention. Now there is a simple blood test that can help uncover and hidden risk for heart attack and stroke. Discover how the PLAC Test can help your physician assess your risk for and prevent these events. >

AJC SupplementNew!

Join us for our next moderated webinar and Q&A session on September 21, 2010. Click here for more information. >

View an on-demand webinar to learn more about Lipoprotein-associated phospholipase A2 (Lp-PLA2) >

AJC Supplement

View the latest news stories, video clips and press releases about the PLAC Test. >

AJC Supplement

Don't miss us as these events!

National Lipid Association
Washington, DC | August 27 - 29, 2010

European Society of Cardiology
Sweden | Aug 28 - Sept 1, 2010

Click here to learn more >